Evidence map›Paper›PMID 29551738›Full record

ArticleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2018

Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus.

Jing Dong, David M Levine, Matthew F Buas, Rui Zhang, Lynn Onstad, Rebecca C Fitzgerald, Stomach and Oesophageal Cancer Study (SOCS) Consortium, Douglas A Corley, Nicholas J Shaheen, Jesper Lagergren and 19 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Esophageal cancer: from pathogenesis to precision therapies.Signal transduction and targeted therapy · 2026
    Review
  2. Carcinoma of Esophagus.Journal of gastroenterology and hepatology · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 19 institutions in 6 countries.

Jing DongSection of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, Texas; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
David M LevineDepartment of Biostatistics, School of Public Health, University of Washington, Seattle, Washington.
Matthew F BuasDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York.
Rui ZhangDepartment of Biostatistics, School of Public Health, University of Washington, Seattle, Washington.
Lynn OnstadDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Rebecca C FitzgeraldMedical Research Council Cancer Unit, Hutchison-MRC Research Centre, University of Cambridge, Cambridge, United Kingdom.
Stomach and Oesophageal Cancer Study (SOCS) Consortium
Douglas A CorleyDivision of Research, Kaiser Permanente Northern California, Oakland, California; San Francisco Medical Center, Kaiser Permanente Northern California, San Francisco, California.
Nicholas J ShaheenDivision of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
Jesper LagergrenDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; School of Cancer Sciences, King's College London, London, United Kingdom.
Laura J HardieDivision of Epidemiology, LICAMM, School of Medicine, University of Leeds, Leeds, United Kingdom.
Brian J ReidDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Prasad G IyerDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Harvey A RischDepartment of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut.
Carlos CaldasCancer Research UK, Cambridge Institute, Cambridge, United Kingdom; Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
Isabel CaldasDepartment of Oncology, University of Cambridge, Cambridge, United Kingdom.
Paul D PharoahDepartment of Oncology, University of Cambridge, Cambridge, United Kingdom; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Geoffrey LiuPharmacogenomic Epidemiology, Ontario Cancer Institute, Toronto, Canada.
Marilie D GammonDepartment of Epidemiology, University of North Carolina, Chapel Hill, North Carolina.
Wong-Ho ChowDepartment of Epidemiology, MD Anderson Cancer Center, Houston, Texas.
Leslie BernsteinDepartment of Population Sciences, Beckman Research Institute and City of Hope Comprehensive Cancer Center, Duarte, California.
Nigel C BirdDepartment of Oncology, Medical School, University of Sheffield, Sheffield, United Kingdom.
Weimin YeDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Anna H WuDepartment of Preventive Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, California.
Lesley A AndersonCentre for Public Health, Queen's University Belfast, Belfast, United Kingdom.
Stuart MacGregorStatistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
David C WhitemanCancer Control, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Thomas L VaughanDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Aaron P ThriftSection of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, Texas; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas. Electronic address: aaron.thrift@bcm.edu.
University of Cambridge · GBFred Hutch Cancer Center · USBaylor College of Medicine · USQIMR Berghofer Medical Research Institute · AUUniversity of North Carolina at Chapel Hill · USUniversity of Washington · USCity of Hope · USKaiser Permanente · USKarolinska Institutet · SEKing's College London · GBMayo Clinic · USOntario Institute for Cancer Research · CAQueen's University Belfast · GBRoswell Park Comprehensive Cancer Center · USThe University of Texas MD Anderson Cancer Center · USUniversity of Leeds · GBUniversity of Sheffield · GBUniversity of Southern California · USYale University · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Dean G. Tang · 1985 to 2026
$116.6M
Translational Research Support CoreP30ES007048 · NIEHS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ROB S MCCONNELL · 1996 to 2026
$46.4M
PHYLOGENIES of Barrett's Esophagus LineagesP01CA091955 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GRADY, WILLIAM MALLORY · 2002 to 2019
$35.9M
PILOT AND FEASIBILITY STUDIESP30DK034987 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Temitope O. Keku · 1985 to 2026
$30.5M
Barrett's and Esophageal Adenocarcinoma Genetic Susceptibility Study (BEAGESS)R01CA136725 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI VAUGHAN, THOMAS L, WHITEMAN, DAVID C · 2009 to 2011
$7.8M
Epidemiology and Incidence of Barrett's EsophagusR01DK063616 · NIDDK · KAISER FOUNDATION RESEARCH INSTITUTE · PI CORLEY, DOUGLAS ALLEN · 2002 to 2010
$2.6M
IKK Signals in Lymphocyte Physiology and PathologyR01AI057947 · NIAID · IMMUNE DISEASE INSTITUTE, INC. · PI RAJEWSKY, KLAUS · 2004 to 2008
$2.3M
ESTABLISHED INVESTIGATOR AWARD IN CANCER PREVENTION AND CONTROLK05CA124911 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI VAUGHAN, THOMAS L · 2007 to 2016
$1.6M
Molecular epidemiology of Barretts esophagus and cancerR01CA001833 · NCI · QUEENSLAND INSTITUTE OF MEDICAL RESEARCH · PI WHITEMAN, DAVID C · 2002 to 2006
$1.3M
EPIDEMIOLOGY OF BARRETTS ESOPHAGUSR01CA072866 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI VAUGHAN, THOMAS L · 1997 to 2000
$543k
Barrett's Esophagus: Risk Factors in WomenR21DK077742 · NIDDK · KAISER FOUNDATION RESEARCH INSTITUTE · PI CORLEY, DOUGLAS ALLEN · 2008 to 2009
$405k
EPIDEMIOLOGIC STUDY OF ESOPHAGEAL/GASTRIC ADENOCARCINOMAU01CA057923 · NCI · YALE UNIVERSITY · PI RISCH, HARVEY A · 1992 to 1995
–
Cancer Research UK 10119Cancer Research UK 16561Cancer Research UK 16942Department of HealthMedical Research Council MC_UU_12022/2NCI NIH HHS K05 CA124911NCI NIH HHS P01 CA091955NCI NIH HHS P30 CA016056NCI NIH HHS R01 CA001833NCI NIH HHS R01 CA072866NCI NIH HHS R01 CA136725NCI NIH HHS U01 CA057923NCI NIH HHS U01 CA057949NCI NIH HHS U01 CA057983NIAID NIH HHS R01 AI057947NIDDK NIH HHS P30 DK034987NIDDK NIH HHS R01 DK063616NIDDK NIH HHS R21 DK077742NIEHS NIH HHS P30 ES007048
6 · The paper itself

Abstract

BACKGROUND &

aimsGenome-wide association studies (GWAS) have identified more than 20 susceptibility loci for esophageal adenocarcinoma (EA) and Barrett's esophagus (BE). However, variants in these loci account for a small fraction of cases of EA and BE. Genetic factors might interact with environmental factors to affect risk of EA and BE. We aimed to identify single nucleotide polymorphisms (SNPs) that may modify the associations of body mass index (BMI), smoking, and gastroesophageal reflux disease (GERD), with risks of EA and BE.

methodsWe collected data on single BMI measurements, smoking status, and symptoms of GERD from 2284 patients with EA, 3104 patients with BE, and 2182 healthy individuals (controls) participating in the Barrett's and Esophageal Adenocarcinoma Consortium GWAS, the UK Barrett's Esophagus Gene Study, and the UK Stomach and Oesophageal Cancer Study. We analyzed 993,501 SNPs in DNA samples of all study subjects. We used standard case-control logistic regression to test for gene-environment interactions.

resultsFor EA, rs13429103 at chromosome 2p25.1, near the RNF144A-LOC339788 gene, showed a borderline significant interaction with smoking status (P = 2.18×10

conclusionThe associations of BMI, smoking, and GERD symptoms with risks of EA and BE appear to vary with SNPs at chromosomes 1, 2, and 15. Validation of these suggestive interactions is warranted.

Indexed as

Environmental ExposureGenetic Predisposition to DiseaseAdenocarcinomaAgedBarrett EsophagusEsophageal NeoplasmsFemaleGenome-Wide Association StudyHumansMaleMiddle AgedPolymorphism, Single NucleotideRisk AssessmentUnited KingdomEsophageal NeoplasmEsophagusGenetic VariantsRisk Factors

Identifiers

PMID29551738
PMCPMC6162842
OpenAlexW2794038966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.